BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 30552981)

  • 1. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
    Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis reveals prognostic role of programmed death ligand-1 in Asian patients with non-small cell lung cancer.
    Hu XY; Zhang W; Hu Y; Zhang Y; Gong R; Liang JY; Liu L
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):313-320. PubMed ID: 27376797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.
    Yu M; Yongzhi H; Chen S; Luo X; Lin Y; Zhou Y; Jin H; Hou B; Deng Y; Tu L; Jian Z
    Oncotarget; 2017 Jun; 8(26):43356-43367. PubMed ID: 28498810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
    Tan Z; Yang C; Zhang X; Zheng P; Shen W
    Oncotarget; 2017 Sep; 8(37):60954-60961. PubMed ID: 28977837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
    Zhao J; Shi X; Wang T; Ying C; He S; Chen Y
    Cell Physiol Biochem; 2017; 43(2):697-704. PubMed ID: 28946136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
    Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
    Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
    Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
    Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
    Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
    Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Min SH; Zheng QQ
    Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
    Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
    PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
    Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
    Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
    World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis.
    Yuan Y; Xu XY; Zheng HG; Hua BJ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4166-4180. PubMed ID: 30024605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.